News
- SiBiono International …
SiBiono International Gene Therapy Sympo… - Cooperation Signing Ce…
Cooperation Signing Ceremony between SiB… - Ms WeiXu, CEO of SiBio…
Ms WeiXu, CEO of SiBiono coming back fro…
Indications and Efficacy
Home - Gendicine - Indications and Efficacy- 今又生已发表文献目录2016-11-25
- A patient2016-11-25
- A phase II2016-11-25
- Clinical study of recombinant2016-11-25
- Effect of Recombinant Adenovirus-p532016-11-25
- 94225-Recombinant adenovirus-p53 (rAd-p53)2016-11-21
- 94224-Recombinant adeno-viral human p53 gene2016-11-21
- 94222-Transcatheter arterial embolization2016-11-21
- 94221-The papers about clinical application of Gendicine2016-11-21
- 94216-P53 Gene Therapy2016-11-21
- 94219-Preoperative recombinant adeno-viral2016-11-21
- 94214-In vitro and Clinical Studies2016-11-21
- 94215-Multiple hepatic arterial injections2016-11-21
- Phase II study of recombinant2011-11-25
- Phase I Study of Repeated IntraepithelialDelivery2011-11-25
Contact us
Add：19,1st Science & Technology Middle Road,Shenzhen Hi-Tech Industry Park(Middle),Shenzhen,P.R.China
Tel：400-6828-666 （086）0755-33065208 0755-33065255
SIBIONO Copyright 粤ICP备14054565号-1